Hawaii Biotech, Inc.
http://www.hibiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hawaii Biotech, Inc.
Zika Vaccines Might Be Approved By 2020
Nothing's even in Phase II yet, but sponsors and US government researchers remain optimistic.
A Snapshot Of Neglected Disease Drug Development: Dengue Fever
Neglected diseases are gaining a higher profile in Big Pharma drug development programs. Research on a vaccine for dengue fever has been ongoing for decades, and a few candidates could finally be nearing late-stage trials.
Sanofi In Phase III Trials For Dengue Vaccine, Offering Emerging Market Potential
Sanofi already generates a substantial share of its revenue from emerging markets, but developing the first dengue vaccine would have significant impact on emerging market revenue, perhaps as early as 2015.
ASEAN issues call for dengue action as cases rise
The 10 member countries of ASEAN (the Association of Southeast Asian Nations) have agreed to collaborate more closely on the prevention, surveillance and treatment of dengue amid a steady rise in the incidence of the disease.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice